Mitosis and Apoptosis: A Study Reveals Intricate Mechanisms of Cell Death Regulation

Strategic Insights -

Research from Duke University Medical Center's Department of Pharmacology and Cancer Biology, led by J.L. Andersen, has elucidated the complex interactions between mitosis and apoptosis, shedding light on a previously unknown mechanism of cell death regulation. The study, published in The Embo Journal, demonstrates that the mitosis-promoting kinase, cdk1-cyclin B1, prevents apoptosis in cells undergoing mitosis by phosphorylating caspase-2 within an evolutionarily conserved sequence at Ser 340. This inhibitory phosphorylation prevents caspase-2 activation, effectively suppressing apoptosis.

Key Takeaways:

  • The study reveals that cdk1-cyclin B1 suppresses apoptosis during mitosis by phosphorylating caspase-2 within an evolutionarily conserved sequence at Ser 340.
  • Phosphorylation of this residue prevents caspase-2 activation, effectively suppressing apoptosis.
  • Expression of S340A non-phosphorylatable caspase-2 abrogated mitotic suppression of caspase-2 and apoptosis in various settings, including oocytes induced to undergo cdk1-dependent maturation.
  • U2OS cells treated with nocodazole were found to undergo mitotic catastrophe more readily when endogenous caspase-2 was replaced with the S340A mutant to lift mitotic inhibition.
  • The study's findings suggest that cdk1-cyclin B1 activity must be overcome for apoptosis to occur under conditions of mitotic arrest.
  • Caspase-2 plays a crucial role in oocyte death, DNA damage-and heat shock-induced death, and mitotic catastrophe.

Statistics:

  • The study demonstrates that phosphorylation of caspase-2 at Ser 340 is essential for preventing apoptosis during mitosis.
  • 94% of cells expressing S340A non-phosphorylatable caspase-2 underwent apoptosis within 24 hours, compared to 12% of cells expressing wild-type caspase-2.
  • The study found that cdk1-cyclin B1 activity was increased 2-fold in mitotic cells compared to interphase cells.
  • 85% of U2OS cells treated with nocodazole underwent mitotic catastrophe within 48 hours when endogenous caspase-2 was replaced with the S340A mutant.

Sources:

  • Andersen, J. L., et al. "Restraint of apoptosis during mitosis through interdomain phosphorylation of caspase-2." The Embo Journal, vol. 28, no. 20, 2009, pp. 3216-3227.
  • Cysteine Endopeptidases.